Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells
Abstract Antibody neutralization of cytomegalovirus (CMV) entry into diverse cell types is a key consideration for development of vaccines and immunotherapeutics. CMV entry into fibroblasts differs significantly from entry into epithelial or endothelial cells: fibroblast entry is mediated by gB and...
Main Authors: | Ying Qi, Li He, Xiaohong Cui, Laura Hertel, Daniel C. Freed, Tong-Ming Fu, Lawrence M. Kauvar, Michael A. McVoy, Qiang Ruan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12985-020-01320-2 |
Similar Items
-
Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells
by: Felix Wussow, et al.
Published: (2017-10-01) -
Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
by: Li He, et al.
Published: (2022-07-01) -
Cytomegalovirus Strain TB40/E Restrictions and Adaptations to Growth in ARPE-19 Epithelial Cells
by: Mai Vo, et al.
Published: (2020-04-01) -
The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus
by: Tobias Cohen, et al.
Published: (2016-10-01) -
Selection of Human Cytomegalovirus Mutants with Resistance against PDGFRα-Derived Entry Inhibitors
by: Kerstin Laib Sampaio, et al.
Published: (2021-06-01)